All TreatGx users now have access to the updated treatment algorithm for Atrial Fibrillation – Rate Control. The updated Rate Control algorithm provides personalized medication treatment options for each patient based on whether they have certain cardiovascular comorbidities , including those with heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, or hypertension. This algorithm continues to provide...
All TreatGx users now have access to the updated algorithms for Chronic Gout and Prevention of Non-Steroidal Anti-Inflammatory (NSAID)-Induced Gastrotoxicity. Chronic Gout: This comprehensive update incorporates information from the most recent clinical guidelines and literature, including updates from the American College of Rheumatology [1], BMJ Best Practice [2], and the European League Against Rheumatism [3]. New information about pharmacogenetic testing for select populations before starting...
All TreatGx users now have access to the updated Generalized Anxiety Disorder treatment algorithm. This comprehensive update incorporates information from the most recent clinical guidelines and literature from the American Family Physician[1], the BMJ[2], Lancet[3], and others. Highlights of the update include: 8 new medication treatment options that have been added based on the latest evidence...
We are pleased to announce the addition of Atrial Fibrillation - Rhythm Control to our TreatGx medication decision support software. The Atrial Fibrillation - Rhythm Control algorithm can now be accessed by all TreatGx users. This algorithm provides long term medication treatment options for the maintenance of sinus rhythm in...
We are pleased to announce the addition of a new condition: Anxiety – Post-Traumatic Stress Disorder to our TreatGx medication decision support software. The PTSD treatment algorithm can be accessed by all TreatGx users. PTSD is a type of anxiety disorder which may develop after...
TreatGx users now have access to the updated Chronic Pain – Low Back Pain treatment algorithm. A key feature of this update is being able to view all medication options at-a-glance. In addition to displaying personalized dosing options based on kidney function, liver function, drug-drug interactions, medical history, and pharmacogenetics (whether available or not), and continuing to provide guidance on gastroprotection in patients at high...
We are pleased to announce the addition of a new condition to our TreatGx website! Ulcerative colitis is now available for access to all TreatGx users. Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that can affect people of all ages. The disease can have a debilitating effect on quality...
With the industry moving towards personalized prescribing, pharmacists have become the key to successful pharmacogenomics (PGx) implementation. In this episode of the Precision Insights Podcast, Adrijana Kekic, PGx pharmacist and the program director of education, outpatient pharmacy at the Mayo Clinic, delves into the ways...
All TreatGx users now have access to the updated Chronic Pain - Neuropathic Pain treatment algorithm. Finding the optimal therapy to meet goals for chronic pain management can be challenging. This major update not only brings together information from multiple sources but enables it to...
Introducing pharmacogenetics to a group of people, a population, can be tricky, but maintaining focus on patient experience, outcomes, and wellbeing can help. In this episode of Precision Insights, Curt Dame, VP of Health Solutions at Aon, explains his experience with implementing pharmacogenetics (PGx) into...
